These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23473055)

  • 1. Role of tyrosine kinase inhibition with imatinib in an encapsulating peritoneal sclerosis rat model.
    Velioglu A; Tugtepe H; Asicioglu E; Yilmaz N; Filinte D; Arikan H; Koc M; Tuglular S; Kaya H; Ozener C
    Ren Fail; 2013; 35(4):531-7. PubMed ID: 23473055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
    Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
    Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
    Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
    Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis.
    Bozkurt D; Sarsik B; Hur E; Ertilav M; Karaca B; Timur O; Bicak S; Akcicek F; Duman S
    J Nephrol; 2011; 24(3):359-65. PubMed ID: 21240876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
    Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
    Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model.
    Bircan L; Karakose S; Unverdi H; Bal AZ; Unverdi S; Duranay M
    Int Urol Nephrol; 2017 May; 49(5):909-916. PubMed ID: 28190234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
    Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
    Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.
    Bozkurt D; Bicak S; Sipahi S; Taskin H; Hur E; Ertilav M; Sen S; Duman S
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S53-7. PubMed ID: 19008543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.
    Bozkurt D; Cetin P; Sipahi S; Hur E; Nar H; Ertilav M; Sezak M; Duman S
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S38-42. PubMed ID: 19008539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis.
    Matsuoka T; Maeda Y; Matsuo K; Naiki Y; Tamai Y; Sakaguchi M; Hasegawa H; Funauchi M; Kanamaru A
    J Nephrol; 2008; 21(1):64-73. PubMed ID: 18264938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats.
    Hur E; Bozkurt D; Timur O; Bicak S; Sarsik B; Akcicek F; Duman S
    Clin Nephrol; 2012 Jan; 77(1):1-7. PubMed ID: 22185962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?
    Bozkurt D; Hur E; Ulkuden B; Sezak M; Nar H; Purclutepe O; Sen S; Duman S
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S202-5. PubMed ID: 19270218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat model.
    Ceri M; Unverdi S; Dogan M; Unverdi H; Karaca G; Kocak G; Kurultak I; Akbal E; Can M; Duranay M
    Int Urol Nephrol; 2012 Jun; 44(3):977-82. PubMed ID: 22528580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
    Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
    Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].
    Dou XR; Yu XQ; Li XY; Chen WF; Hao WK; Jia ZJ; Peng WX; Wang X; Yin PD; Wang WJ; Zheng ZH
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2613-8. PubMed ID: 16321321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-β, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis.
    Saglam F; Cavdar Z; Sarioglu S; Kolatan E; Oktay G; Yilmaz O; Camsari T
    Ren Fail; 2012; 34(1):95-102. PubMed ID: 22136281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis.
    Kim KH; Ryu HM; Oh SH; Oh EJ; Ahn JS; Lee JH; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Ther Apher Dial; 2014 Dec; 18(6):628-36. PubMed ID: 25256793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.
    Huddam B; Başaran M; Koçak G; Azak A; Yalçın F; Reyhan NH; Duranay M
    Int Urol Nephrol; 2015 Aug; 47(8):1423-8. PubMed ID: 26159779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.
    Kushiyama T; Oda T; Yamada M; Higashi K; Yamamoto K; Oshima N; Sakurai Y; Miura S; Kumagai H
    Nephrol Dial Transplant; 2011 Oct; 26(10):3143-54. PubMed ID: 21362737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.